Cargando…
6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer
Genetic and epigenetic alterations have been identified as to contribute directly or indirectly to the generation of transitional cell carcinoma of the urinary bladder (TCC-UB). In a comparative fashion much less is known about copy number alterations in TCC-UB, but it appears that amplification of...
Autores principales: | Shen, He, Morrison, Carl D., Zhang, Jianmin, Underwood, Willie, Yang, Nuo, Frangou, Costa, Eng, Kevin, Head, Karen, Bollag, Roni J., Kavuri, Sravan K., Rojiani, Amyn M., Li, Yingwei, Yan, Li, Hill, Annette, Woloszynska-Read, Anna, Wang, Jianmin, Liu, Song, Trump, Donald L., Candace, Johnson S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875774/ https://www.ncbi.nlm.nih.gov/pubmed/24231253 |
Ejemplares similares
-
Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer
por: Wu, Qiong, et al.
Publicado: (2005) -
Vitamin D(3) enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk
por: Bunch, Brittany L., et al.
Publicado: (2019) -
Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges
por: Liu, Biao, et al.
Publicado: (2013) -
Loss of KIBRA function activates EGFR signaling by inducing AREG
por: Mussell, Ashley L., et al.
Publicado: (2018) -
Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome
por: Shen, He, et al.
Publicado: (2015)